WallStSmart

R1 RCM Inc (RCM)vsTalkspace Inc (TALK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

R1 RCM Inc generates 976% more annual revenue ($2.46B vs $228.87M). TALK leads profitability with a 3.4% profit margin vs -2.5%. TALK earns a higher WallStSmart Score of 45/100 (D).

RCM

Hold

39

out of 100

Grade: F

Growth: 6.0Profit: 3.0Value: 6.7Quality: 5.0

TALK

Hold

45

out of 100

Grade: D

Growth: 7.3Profit: 4.5Value: 3.0Quality: 7.8
Piotroski: 4/9Altman Z: 3.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for RCM.

TALKSignificantly Overvalued (-102.1%)

Margin of Safety

-102.1%

Fair Value

$1.87

Current Price

$5.13

$3.26 premium

UndervaluedFair: $1.87Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RCM1 strengths · Avg: 8.0/10
Price/BookValuation
2.1x8/10

Reasonable price relative to book value

TALK2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.9510/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
29.3%8/10

Revenue surging 29.3% year-over-year

Areas to Watch

RCM4 concerns · Avg: 2.8/10
PEG RatioValuation
2.064/10

Expensive relative to growth rate

Operating MarginProfitability
3.8%3/10

Operating margin of 3.8%

Return on EquityProfitability
-2.2%2/10

ROE of -2.2% — below average capital efficiency

EPS GrowthGrowth
-99.3%2/10

Earnings declined 99.3%

TALK4 concerns · Avg: 3.3/10
EPS GrowthGrowth
1.8%4/10

1.8% earnings growth

Market CapQuality
$857.10M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.7%3/10

ROE of 6.7% — below average capital efficiency

Profit MarginProfitability
3.4%3/10

3.4% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : RCM

The strongest argument for RCM centers on Price/Book. Revenue growth of 14.7% demonstrates continued momentum.

Bull Case : TALK

The strongest argument for TALK centers on Altman Z-Score, Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.

Bear Case : RCM

The primary concerns for RCM are PEG Ratio, Operating Margin, Return on Equity.

Bear Case : TALK

The primary concerns for TALK are EPS Growth, Market Cap, Return on Equity. A P/E of 128.3x leaves little room for execution misses. Thin 3.4% margins leave little buffer for downturns.

Key Dynamics to Monitor

RCM profiles as a turnaround stock while TALK is a growth play — different risk/reward profiles.

TALK carries more volatility with a beta of 1.21 — expect wider price swings.

TALK is growing revenue faster at 29.3% — sustainability is the question.

RCM generates stronger free cash flow (60M), providing more financial flexibility.

Bottom Line

TALK scores higher overall (45/100 vs 39/100) and 29.3% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

R1 RCM Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

R1 RCM Inc (RCM) is a leading provider of technology-enabled revenue cycle management services, specializing in optimizing the financial performance of healthcare organizations. By leveraging advanced analytics and industry expertise, R1 RCM delivers comprehensive solutions that streamline patient billing processes and enhance operational efficiencies across a diverse portfolio of clients, including hospitals and outpatient facilities. The company's innovative approach not only improves revenue capture but also elevates the patient experience, positioning R1 RCM as a key player in the evolving healthcare landscape. With a robust growth strategy focused on expanding its service offerings and market reach, R1 RCM is poised to capitalize on the increasing demand for effective revenue cycle solutions in the healthcare sector.

Talkspace Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Talkspace Inc. is a virtual behavioral healthcare company. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?